Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon

NCT00297882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

816

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: 1. Artemether-Lumefantrine (AL)
DRUG: 2. Amodiaquine-Artesunate (AQ-AS)

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]
[object Object]